Cargando…

Anti-Integrins for the Treatment of Inflammatory Bowel Disease: Current Evidence and Perspectives

Leukocyte trafficking to the gastrointestinal tract is recognized to play a role in the pathogenesis of inflammatory bowel disease (IBD). Integrins are expressed on immune cells and interact with cell adhesion molecules (CAM) to mediate leukocyte trafficking. Blockade of the gut-tropic integrin α4β7...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gubatan, John, Keyashian, Kian, Rubin, Samuel J S, Wang, Jenny, Buckman, Cyrus A, Sinha, Sidhartha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402953/ https://www.ncbi.nlm.nih.gov/pubmed/34466013 http://dx.doi.org/10.2147/CEG.S293272

Ejemplares similares

Small bowel adenocarcinoma in neoterminal ileum in setting of stricturing Crohn’s disease: A case report and review of literature
por: Karthikeyan, Shruthi, et al.
Publicado: (2023)

Dietary Exposures and Interventions in Inflammatory Bowel Disease: Current Evidence and Emerging Concepts
por: Gubatan, John, et al.
Publicado: (2023)

Novel Topics in Inflammatory Bowel Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2016)

Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions
por: Gubatan, John, et al.
Publicado: (2021)

Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease
por: Weingarden, Alexa R, et al.
Publicado: (2021)

Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy
por: Rubin, Samuel J S, et al.
Publicado: (2022)

Antimicrobial peptides and the gut microbiome in inflammatory bowel disease
por: Gubatan, John, et al.
Publicado: (2021)

Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer
por: Gubatan, John, et al.
Publicado: (2022)

Anti-integrin therapy for inflammatory bowel disease
por: Park, Sung Chul, et al.
Publicado: (2018)

Reply
por: Gubatan, John, et al.
Publicado: (2021)

1162: SINGLE-CELL IMMUNE PROFILING AND REPERTOIRE ANALYSIS OF CONVALESCENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND SARS-COV-2 ANTIBODY RESPONSE
por: Gubatan, John Mark, et al.
Publicado: (2022)

The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti‐integrin therapies
por: Dotan, Iris, et al.
Publicado: (2019)

Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective
por: Axelrad, Jordan E, et al.
Publicado: (2016)

Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases
por: Rubin, Samuel J. S., et al.
Publicado: (2019)

Managing vitamin D deficiency in inflammatory bowel disease
por: Nielsen, Ole Haagen, et al.
Publicado: (2019)

Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
por: Singh, Harmanjit, et al.
Publicado: (2016)

Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel Disease
por: Temby, Michelle, et al.
Publicado: (2023)

Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
por: Rath, Timo, et al.
Publicado: (2018)

Calreticulin and integrin alpha dissociation induces anti-inflammatory programming in animal models of inflammatory bowel disease
por: Ohkuro, Masayoshi, et al.
Publicado: (2018)

Managing inflammatory bowel disease in pregnancy: current perspectives
por: Pinder, Matthew, et al.
Publicado: (2016)

Exercise in patients with inflammatory bowel diseases: current perspectives
por: Engels, Michael, et al.
Publicado: (2017)

Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease
por: Na, Soo-Young, et al.
Publicado: (2019)

Regulation and Role of αE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease
por: Keir, Mary E., et al.
Publicado: (2021)

Efficacy of Dietary Supplements in Inflammatory Bowel Disease and Related Autoimmune Diseases
por: Jadhav, Priyanka, et al.
Publicado: (2020)

Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases
por: Jiang, Yan, et al.
Publicado: (2021)

SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
por: Gubatan, John, et al.
Publicado: (2020)

The Multiple Faces of Integrin–ECM Interactions in Inflammatory Bowel Disease
por: Garlatti, Valentina, et al.
Publicado: (2021)

Treating children with inflammatory bowel disease: Current and new perspectives
por: Guariso, Graziella, et al.
Publicado: (2017)

Gut microbiota and inflammatory bowel disease: The current status and perspectives
por: Zheng, Lie, et al.
Publicado: (2021)

Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence
por: Misra, Sanghamitra M.
Publicado: (2014)

The Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Neither Hot nor Cold
por: Rubin, Samuel J. S., et al.
Publicado: (2022)

Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases
por: Park, Sang Hyoung, et al.
Publicado: (2020)

The Gut-Brain Axis in Inflammatory Bowel Disease—Current and Future Perspectives
por: Günther, Claudia, et al.
Publicado: (2021)

The role of Akkermansia muciniphila in inflammatory bowel disease: Current knowledge and perspectives
por: Zheng, Mengyu, et al.
Publicado: (2023)

Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease
por: Becker, Heike E. F., et al.
Publicado: (2023)

Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence
por: Fons, Anne, et al.
Publicado: (2023)

Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions
por: Dubinsky, Marla, et al.
Publicado: (2023)

Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
por: Rawla, Prashanth, et al.
Publicado: (2018)

Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives
por: Assadsangabi, Arash, et al.
Publicado: (2019)

Personalized Dietary Regimens for Inflammatory Bowel Disease: Current Knowledge and Future Perspectives
por: Wellens, Judith, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kthhtdd352imefkt3r4r1d7slt